109 related articles for article (PubMed ID: 22889416)
1. Design, synthesis, and pharmacological evaluation of novel hybrid compounds to treat sickle cell disease symptoms. part II: furoxan derivatives.
Dos Santos JL; Lanaro C; Chelucci RC; Gambero S; Bosquesi PL; Reis JS; Lima LM; Cerecetto H; González M; Costa FF; Chung MC
J Med Chem; 2012 Sep; 55(17):7583-92. PubMed ID: 22889416
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and pharmacological evaluation of novel hybrid compounds to treat sickle cell disease symptoms.
dos Santos JL; Lanaro C; Lima LM; Gambero S; Franco-Penteado CF; Alexandre-Moreira MS; Wade M; Yerigenahally S; Kutlar A; Meiler SE; Costa FF; Chung M
J Med Chem; 2011 Aug; 54(16):5811-9. PubMed ID: 21766854
[TBL] [Abstract][Full Text] [Related]
3. Discovery of phenylsulfonylfuroxan derivatives as gamma globin inducers by histone acetylation.
Melo TRF; Kumkhaek C; Fernandes GFDS; Lopes Pires ME; Chelucci RC; Barbieri KP; Coelho F; Capote TSO; Lanaro C; Carlos IZ; Marcondes S; Chegaev K; Guglielmo S; Fruttero R; Chung MC; Costa FF; Rodgers GP; Dos Santos JL
Eur J Med Chem; 2018 Jun; 154():341-353. PubMed ID: 29852459
[TBL] [Abstract][Full Text] [Related]
4. Antitumor platinum(II) complexes containing platinum-based moieties of present platinum drugs and furoxan groups as nitric oxide donors: synthesis, DNA interaction, and cytotoxicity.
Zhao J; Gou S; Sun Y; Fang L; Wang Z
Inorg Chem; 2012 Oct; 51(19):10317-24. PubMed ID: 22957695
[TBL] [Abstract][Full Text] [Related]
5. Novel nitric oxide-releasing derivatives of farnesylthiosalicylic acid: synthesis and evaluation of antihepatocellular carcinoma activity.
Ling Y; Ye X; Zhang Z; Zhang Y; Lai Y; Ji H; Peng S; Tian J
J Med Chem; 2011 May; 54(9):3251-9. PubMed ID: 21504204
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of 3,4-diphenyl-1,2,5-oxadiazole-2-oxides and 3,4-diphenyl-1,2,5-oxadiazoles as potential hybrid COX-2 inhibitor/nitric oxide donor agents.
Velázquez C; Rao PN; McDonald R; Knaus EE
Bioorg Med Chem; 2005 Apr; 13(8):2749-57. PubMed ID: 15781386
[TBL] [Abstract][Full Text] [Related]
7. Second generation of alpha-tocopherol analogs-nitric oxide donors: Synthesis, physicochemical, and biological characterization.
López GV; Blanco F; Hernández P; Ferreira A; Piro OE; Batthyány C; González M; Rubbo H; Cerecetto H
Bioorg Med Chem; 2007 Sep; 15(18):6262-72. PubMed ID: 17627828
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide donor beta2-agonists: furoxan derivatives containing the fenoterol moiety and related furazans.
Buonsanti MF; Bertinaria M; Stilo AD; Cena C; Fruttero R; Gasco A
J Med Chem; 2007 Oct; 50(20):5003-11. PubMed ID: 17845020
[TBL] [Abstract][Full Text] [Related]
9. Increased adhesive properties of neutrophils in sickle cell disease may be reversed by pharmacological nitric oxide donation.
Canalli AA; Franco-Penteado CF; Saad ST; Conran N; Costa FF
Haematologica; 2008 Apr; 93(4):605-9. PubMed ID: 18326523
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and in vitro NO-releasing activities of ocotillol-type furoxans.
Bi Y; Yang J; Ma C; Liu ZY; Zhang TT; Zhang XC; Lu J; Meng QG
Pharmazie; 2015 Apr; 70(4):213-8. PubMed ID: 26012249
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of furoxan derivatives against Mycobacterium tuberculosis.
Fernandes GFDS; de Souza PC; Marino LB; Chegaev K; Guglielmo S; Lazzarato L; Fruttero R; Chung MC; Pavan FR; Dos Santos JL
Eur J Med Chem; 2016 Nov; 123():523-531. PubMed ID: 27508879
[TBL] [Abstract][Full Text] [Related]
12. New 1,4-dihydropyridines conjugated to furoxanyl moieties, endowed with both nitric oxide-like and calcium channel antagonist vasodilator activities.
Di Stilo A; Visentin S; Cena C; Gasco AM; Ermondi G; Gasco A
J Med Chem; 1998 Dec; 41(27):5393-401. PubMed ID: 9876109
[TBL] [Abstract][Full Text] [Related]
13. Aroylpropionic acid based 2,5-disubstituted-1,3,4-oxadiazoles: synthesis and their anti-inflammatory and analgesic activities.
Akhter M; Husain A; Azad B; Ajmal M
Eur J Med Chem; 2009 Jun; 44(6):2372-8. PubMed ID: 18977556
[TBL] [Abstract][Full Text] [Related]
14. The furoxan system: design of selective nitric oxide (NO) donor inhibitors of COX-2 endowed with anti-aggregatory and vasodilating activities.
Del Grosso E; Boschi D; Lazzarato L; Cena C; Di Stilo A; Fruttero R; Moro S; Gasco A
Chem Biodivers; 2005 Jul; 2(7):886-900. PubMed ID: 17193179
[TBL] [Abstract][Full Text] [Related]
15. Study of synthesis and cardiovascular activity of some furoxan derivatives as potential NO-donors.
Mu L; Feng SS; Go ML
Chem Pharm Bull (Tokyo); 2000 Jun; 48(6):808-16. PubMed ID: 10866141
[TBL] [Abstract][Full Text] [Related]
16. New potential uroselective NO-donor alpha1-antagonists.
Boschi D; Tron GC; Di Stilo A; Fruttero R; Gasco A; Poggesi E; Motta G; Leonardi A
J Med Chem; 2003 Aug; 46(17):3762-5. PubMed ID: 12904082
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of furoxan-based nitric oxide-releasing glucocorticoid derivatives with potent anti-inflammatory activity and improved safety.
Fang L; Zhang Y; Lehmann J; Wang Y; Ji H; Ding D
Bioorg Med Chem Lett; 2007 Feb; 17(4):1062-6. PubMed ID: 17129724
[TBL] [Abstract][Full Text] [Related]
18. Discovery of new orally effective analgesic and anti-inflammatory hybrid furoxanyl N-acylhydrazone derivatives.
Hernández P; Cabrera M; Lavaggi ML; Celano L; Tiscornia I; Rodrigues da Costa T; Thomson L; Bollati-Fogolín M; Miranda AL; Lima LM; Barreiro EJ; González M; Cerecetto H
Bioorg Med Chem; 2012 Mar; 20(6):2158-71. PubMed ID: 22356737
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of novel senkyunolide analogues as neuroprotective agents.
Fang Y; Wang R; Wang Q; Sun Y; Xie S; Yang Z; Li M; Jin Y; Yang S
Bioorg Med Chem Lett; 2018 Feb; 28(4):668-672. PubMed ID: 29370975
[TBL] [Abstract][Full Text] [Related]
20. Searching for new NO-donor aspirin-like molecules: Furoxanylacyl derivatives of salicylic acid and related furazans.
Lazzarato L; Cena C; Rolando B; Marini E; Lolli ML; Guglielmo S; Guaita E; Morini G; Coruzzi G; Fruttero R; Gasco A
Bioorg Med Chem; 2011 Oct; 19(19):5852-60. PubMed ID: 21906954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
